TALIA BARZEL BAKER portrait
  • Professor, Surgery

Languages

  • English, Fluent.

Publications

  • Siddiqi UA, Hibino N, Combs PS, Baker T, Song T, Kim G, Jeevanandam V (date unknown). A successful heart and liver transplantation requiring intraoperative extracorporeal membrane oxygenation for primary cardiac allograft dysfunction in a patient with Fontan failure. (pp. 1357-1359). Vol. 35. Accepted, .
  • Baker TB (date unknown). Liver Paired Exchange: Ready for Prime Time in North America?. Vol. 25, 1609-1610. Accepted, .
  • Ladner DP, Baker T (date unknown). Near-miss events: a vastly missed opportunity. Vol. 19, 467-9. Accepted, .
  • Baker TB (date unknown). Living liver donation, donor safety, and social media: Preparing for a new frontier. Vol. 23, 131-132. Accepted, .
  • Boyarsky BJ, Ruck JM, Chiang TP, Werbel WA, Strauss AT, Getsin SN, Jackson KR, Kernodle AB, Van Pilsum Rasmussen SE, Baker TB, Al Ammary F, Durand CM, Avery RK, Massie AB, Segev DL, Garonzik-Wang JM (date unknown). Evolving Impact of COVID-19 on Transplant Center Practices and Policies in the United States. Vol. 34, e14086. Accepted, .
  • Baker TB, Zimmerman MA, Goodrich NP, Samstein B, Pomfret EA, Pomposelli JJ, Gillespie BW, Berg CL, Emond JC, Merion RM (date unknown). Biliary reconstructive techniques and associated anatomic variants in adult living donor liver transplantations: The adult-to-adult living donor liver transplantation cohort study experience. Vol. 23, 1519-1530. Accepted, .
  • Thornburg B, Desai K, Hickey R, Hohlastos E, Kulik L, Ganger D, Baker T, Abecassis M, Caicedo JC, Ladner D, Fryer J, Riaz A, Lewandowski RJ, Salem R (date unknown). Pretransplantation Portal Vein Recanalization and Transjugular Intrahepatic Portosystemic Shunt Creation for Chronic Portal Vein Thrombosis: Final Analysis of a 61-Patient Cohort. Vol. 28, 1714-1721.e2. Accepted, .
  • Gabr A, Kallini JR, Gates VL, Hickey R, Kulik L, Desai K, Thornburg B, Marshall K, Salzig K, Williams M, Del Castillo C, Ganger D, Hohlastos E, Baker T, Lewandowski RJ, Salem R (date unknown). Same-day 90Y radioembolization: implementing a new treatment paradigm. Vol. 43, 2353-2359. Accepted, .
  • Levitsky J, Baker TB, Jie C, Ahya S, Levin M, Friedewald J, Al-Saden P, Salomon DR, Abecassis MM (date unknown). Plasma protein biomarkers enhance the clinical prediction of kidney injury recovery in patients undergoing liver transplantation. Vol. 60, 2017-26. Accepted, .
  • Spanier T, Smith CR, Burkhoff D (date unknown). Angiogenesis: a possible mechanism underlying the clinical benefits of transmyocardial laser revascularization. Vol. 15, 269-73. Accepted, .
  • Spanier TB, Burkhoff D, Smith CR (date unknown). Role for holmium:YAG lasers in transmyocardial laser revascularization. Vol. 15, 287-91. Accepted, .
  • Chen JM, Cullinane S, Spanier TB, Artrip JH, John R, Edwards NM, Oz MC, Landry DW (date unknown). Vasopressin deficiency and pressor hypersensitivity in hemodynamically unstable organ donors. Vol. 100, II244-6. Accepted, .
  • Gabr A, Abouchaleh N, Ali R, Baker T, Caicedo J, Katariya N, Abecassis M, Riaz A, Lewandowski RJ, Salem R (date unknown). Outcomes of Surgical Resection after Radioembolization for Hepatocellular Carcinoma. Vol. 29, 1502-1510.e1. Accepted, .
  • Salem R, Vouche M, Baker T, Herrero JI, Caicedo JC, Fryer J, Hickey R, Habib A, Abecassis M, Koller F, Vogelzang R, Desai K, Thornburg B, Hohlastos E, Resnick S, Lewandowski RJ, Sato K, Ryu RK, Ganger D, Kulik L (date unknown). Pretransplant Portal Vein Recanalization-Transjugular Intrahepatic Portosystemic Shunt in Patients With Complete Obliterative Portal Vein Thrombosis. Vol. 99, 2347-55. Accepted, .
  • Vouche M, Kulik L, Atassi R, Memon K, Hickey R, Ganger D, Miller FH, Yaghmai V, Abecassis M, Baker T, Mulcahy M, Nayar R, Lewandowski RJ, Salem R (date unknown). Radiological-pathological analysis of WHO, RECIST, EASL, mRECIST and DWI: Imaging analysis from a prospective randomized trial of Y90 ± sorafenib. Vol. 58, 1655-66. Accepted, .
  • Vouche M, Lewandowski RJ, Atassi R, Memon K, Gates VL, Ryu RK, Gaba RC, Mulcahy MF, Baker T, Sato K, Hickey R, Ganger D, Riaz A, Fryer J, Caicedo JC, Abecassis M, Kulik L, Salem R (date unknown). Radiation lobectomy: time-dependent analysis of future liver remnant volume in unresectable liver cancer as a bridge to resection. Vol. 59, 1029-36. Accepted, .
  • Spanier TB, Chen JM, Oz MC, Edwards NM, Kisiel W, Stern DM, Rose EA, Schmidt AM (date unknown). Selective anticoagulation with active site-blocked factor IXA suggests separate roles for intrinsic and extrinsic coagulation pathways in cardiopulmonary bypass. Vol. 116, 860-9. Accepted, .
  • Dewey TM, Chen JM, Spanier TB, Oz MC (date unknown). Alternative technique of right-sided outflow cannula insertion for right ventricular support. Vol. 66, 1829-30. Accepted, .
  • Bodzin AS, Baker TB (date unknown). Liver Transplantation Today: Where We Are Now and Where We Are Going. Vol. 24, 1470-1475. Accepted, .
  • Emond JC, Goodrich NP, Pomposelli JJ, Baker TB, Humar A, Grant DR, Abt P, Friese CE, Fisher RA, Kam I, Sherker AH, Gillespie BW, Merion RM (date unknown). Hepatic Hemodynamics and Portal Flow Modulation: The A2ALL Experience. Vol. 101, 2375-2384. Accepted, .
  • Gordon EJ, Rodde J, Skaro A, Baker T (date unknown). Informed consent for live liver donors: A qualitative, prospective study. Vol. 63, 838-47. Accepted, .
  • Gordon EJ, Mullee J, Butt Z, Kang J, Baker T (date unknown). Optimizing informed consent in living liver donors: Evaluation of a comprehension assessment tool. Vol. 21, 1270-9. Accepted, .
  • McElroy LM, Daud A, Davis AE, Lapin B, Baker T, Abecassis MM, Levitsky J, Holl JL, Ladner DP (date unknown). A meta-analysis of complications following deceased donor liver transplant. Vol. 208, 605-18. Accepted, .
  • Salem R, Gilbertsen M, Butt Z, Memon K, Vouche M, Hickey R, Baker T, Abecassis MM, Atassi R, Riaz A, Cella D, Burns JL, Ganger D, Benson AB 3rd, Mulcahy MF, Kulik L, Lewandowski R (date unknown). Increased quality of life among hepatocellular carcinoma patients treated with radioembolization, compared with chemoembolization. Vol. 11, 1358-1365.e1. Accepted, .
  • Leventhal JR, Kocak B, Salvalaggio PR, Koffron AJ, Baker TB, Kaufman DB, Fryer JP, Abecassis MM, Stuart FP (date unknown). Laparoscopic donor nephrectomy 1997 to 2003: lessons learned with 500 cases at a single institution. Vol. 136, 881-90. Accepted, .
  • Spanier T, Oz M, Levin H, Weinberg A, Stamatis K, Stern D, Rose E, Schmidt AM (date unknown). Activation of coagulation and fibrinolytic pathways in patients with left ventricular assist devices. Vol. 112, 1090-7. Accepted, .
  • Lewandowski RJ, Andreoli JM, Hickey R, Kallini JR, Gabr A, Baker T, Kircher S, Salem R, Kulik L (date unknown). Angiogenic Response following Radioembolization: Results from a Randomized Pilot Study of Yttrium-90 with or without Sorafenib. Vol. 27, 1329-1336. Accepted, .
  • Gordon EJ, Mullee J, Skaro A, Baker T (date unknown). Live liver donors' information needs: A qualitative study of practical implications for informed consent. Vol. 160, 671-82. Accepted, .
  • Olthoff KM, Smith AR, Abecassis M, Baker T, Emond JC, Berg CL, Beil CA, Burton JR Jr, Fisher RA, Freise CE, Gillespie BW, Grant DR, Humar A, Kam I, Merion RM, Pomfret EA, Samstein B, Shaked A (date unknown). Defining long-term outcomes with living donor liver transplantation in North America. Vol. 262, 465-75; discussion 473-5. Accepted, .
  • Chang Y, Gallon L, Jay C, Shetty K, Ho B, Levitsky J, Baker T, Ladner D, Friedewald J, Abecassis M, Hazen G, Skaro AI (date unknown). Comparative effectiveness of liver transplant strategies for end-stage liver disease patients on renal replacement therapy. Vol. 20, 1034-44. Accepted, .
  • Williams MR, D'Ambra AB, Beck JR, Spanier TB, Morales DL, Helman DN, Oz MC (date unknown). A randomized trial of antithrombin concentrate for treatment of heparin resistance. Vol. 70, 873-7. Accepted, .
  • Spanier T, Tector K, Schwartz G, Chen J, Oz M, Beck J, Mongero L (date unknown). Endotoxin in pooled pericardial blood contributes to the systemic inflammatory response during cardiac surgery. Vol. 15, 427-31. Accepted, .
  • Spanier TB, Chen JM, Mancini DM, Smith CR, Edwards NM (date unknown). Cardiac transplantation in a patient with protein S deficiency. Vol. 68, 1078-80. Accepted, .
  • Spanier TB, Chen JM, Oz MC, Stern DM, Rose EA, Schmidt AM (date unknown). Time-dependent cellular population of textured-surface left ventricular assist devices contributes to the development of a biphasic systemic procoagulant response. Vol. 118, 404-13. Accepted, .
  • Spanier TB, Oz MC, Madigan JD, Rose EA, Stern DM, Nowygrod R, Schmidt AM (date unknown). Selective anticoagulation with active site blocked factor IXa in synthetic patch vascular repair results in decreased blood loss and operative time. Vol. 43, M526-30. Accepted, .
  • Ankersmit HJ, Tugulea S, Spanier T, Weinberg AD, Artrip JH, Burke EM, Flannery M, Mancini D, Rose EA, Edwards NM, Oz MC, Itescu S (date unknown). Activation-induced T-cell death and immune dysfunction after implantation of left-ventricular assist device. Vol. 354, 550-5. Accepted, .
  • Kulik L, Vouche M, Koppe S, Lewandowski RJ, Mulcahy MF, Ganger D, Habib A, Karp J, Al-Saden P, Lacouture M, Cotliar J, Abecassis M, Baker T, Salem R (date unknown). Prospective randomized pilot study of Y90+/-sorafenib as bridge to transplantation in hepatocellular carcinoma. Vol. 61, 309-17. Accepted, .
  • Mouli S, Memon K, Baker T, Benson AB 3rd, Mulcahy MF, Gupta R, Ryu RK, Salem R, Lewandowski RJ (date unknown). Yttrium-90 radioembolization for intrahepatic cholangiocarcinoma: safety, response, and survival analysis. Vol. 24, 1227-34. Accepted, .
  • Sun BC, Catanese KA, Spanier TB, Flannery MR, Gardocki MT, Marcus LS, Levin HR, Rose EA, Oz MC (date unknown). 100 long-term implantable left ventricular assist devices: the Columbia Presbyterian interim experience. Vol. 68, 688-94. Accepted, .
  • Lewandowski RJ, Donahue L, Chokechanachaisakul A, Kulik L, Mouli S, Caicedo J, Abecassis M, Fryer J, Salem R, Baker T (date unknown). (90) Y radiation lobectomy: Outcomes following surgical resection in patients with hepatic tumors and small future liver remnant volumes. Vol. 114, 99-105. Accepted, .
  • Pomposelli JJ, Goodrich NP, Emond JC, Humar A, Baker TB, Grant DR, Fisher RA, Roberts JP, Olthoff KM, Gillespie BW, Merion RM (date unknown). Patterns of Early Allograft Dysfunction in Adult Live Donor Liver Transplantation: The A2ALL Experience. Vol. 100, 1490-9. Accepted, .
  • Memon K, Kulik LM, Lewandowski RJ, Wang E, Wang J, Ryu RK, Hickey R, Vouche M, Baker T, Ganger D, Gates VL, Habib A, Mulcahy MF, Salem R (date unknown). Comparative study of staging systems for hepatocellular carcinoma in 428 patients treated with radioembolization. Vol. 25, 1056-66. Accepted, .
  • Vouche M, Habib A, Ward TJ, Kim E, Kulik L, Ganger D, Mulcahy M, Baker T, Abecassis M, Sato KT, Caicedo JC, Fryer J, Hickey R, Hohlastos E, Lewandowski RJ, Salem R (date unknown). Unresectable solitary hepatocellular carcinoma not amenable to radiofrequency ablation: multicenter radiology-pathology correlation and survival of radiation segmentectomy. Vol. 60, 192-201. Accepted, .
  • Smith CR, Spanier TB (date unknown). Aprotinin in deep hypothermic circulatory arrest. Vol. 68, 278-86. Accepted, .
  • Chen JM, DeRose JJ, Slater JP, Spanier TB, Dewey TM, Catanese KA, Flannery MA, Oz MC (date unknown). Improved survival rates support left ventricular assist device implantation early after myocardial infarction. Vol. 33, 1903-8. Accepted, .
  • Strauss AT, Boyarsky BJ, Garonzik-Wang JM, Werbel W, Durand CM, Avery RK, Jackson KR, Kernodle AB, Baker T, Snyder J, Segev DL, Massie AB (date unknown). Liver transplantation in the United States during the COVID-19 pandemic: National and center-level responses. Vol. 21, 1838-1847. Accepted, .
  • Spanier TB, Oz MC, Minanov OP, Simantov R, Kisiel W, Stern DM, Rose EA, Schmidt AM (date unknown). Heparinless cardiopulmonary bypass with active-site blocked factor IXa: a preliminary study on the dog. Vol. 115, 1179-88. Accepted, .
  • Jayant K, Reccia I, Virdis F, Pyda JS, Bachul PJ, di Sabato D, Barth RN, Fung J, Baker T, Witkowski P (date unknown). COVID-19 in hospitalized liver transplant recipients: An early systematic review and meta-analysis. Vol. 35, e14246. Accepted, .
  • Chen JM, Spanier TB, Gonzalez JJ, Marelli D, Flannery MA, Tector KA, Cullinane S, Oz MC (date unknown). Improved survival in patients with acute myocarditis using external pulsatile mechanical ventricular assistance. Vol. 18, 351-7. Accepted, .
  • Soubrane O, Eguchi S, Uemoto S, Kwon CHD, Wakabayashi G, Han HS, Kim KH, Troisi RI, Cherqui D, Rotellar F, Cauchy F, Soyama A, Ogiso S, Choi GS, Takahara T, Cho JY, Cho HD, Vanlander A, Pittau G, Scatton O, Pardo F, Baker T (date unknown). Minimally Invasive Donor Hepatectomy for Adult Living Donor Liver Transplantation: An International, Multi-Institutional Evaluation of Safety, Efficacy and Early Outcomes. Accepted, .
  • Gabr A, Kulik L, Mouli S, Riaz A, Ali R, Desai K, Mora RA, Ganger D, Maddur H, Flamm S, Boike J, Moore C, Thornburg B, Alasadi A, Baker T, Borja-Cacho D, Katariya N, Ladner DP, Caicedo JC, Lewandowski RJ, Salem R (date unknown). Liver Transplantation Following Yttrium-90 Radioembolization: 15-Year Experience in 207-Patient Cohort. Vol. 73, 998-1010. Accepted, .
  • Badar W, Van Ha T, Zangan S, Navuluri R, Pillai A, Baker T, Dalag L, Han R, Ahmed O (date unknown). Safety and efficacy of repeat Y90 radioembolization to the same hepatic arterial territory. Vol. 94, 20200752. Accepted, .
  • Benjamin AJ, Baker TB, Talamonti MS, Bodzin AS, Schneider AB, Winschester DJ, Roggin KK, Bentrem DJ, Suss NR, Baker MS (date unknown). Liver transplant offers a survival benefit over margin negative resection in patients with small unifocal hepatocellular carcinoma and preserved liver function. Vol. 163, 582-586. Accepted, .
  • Thornburg B, Desai K, Hickey R, Kulik L, Ganger D, Baker T, Abecassis M, Lewandowski RJ, Salem R (date unknown). Portal Vein Recanalization and Transjugular Intrahepatic Portosystemic Shunt Creation for Chronic Portal Vein Thrombosis: Technical Considerations. Vol. 19, 52-60. Accepted, .
  • Zimmerman MA, Baker T, Goodrich NP, Freise C, Hong JC, Kumer S, Abt P, Cotterell AH, Samstein B, Everhart JE, Merion RM (date unknown). Development, management, and resolution of biliary complications after living and deceased donor liver transplantation: a report from the adult-to-adult living donor liver transplantation cohort study consortium. Vol. 19, 259-67. Accepted, .
  • Mongero LB, Beck JR, Manspeizer HE, Heyer EJ, Lee K, Spanier TA, Smith CR (date unknown). Cardiac surgical patients exposed to heparin-bonded circuits develop less postoperative cerebral dysfunction than patients exposed to non-heparin-bonded circuits. Vol. 16, 107-11. Accepted, .
  • Spanier TB, Klein RD, Nasraway SA, Rand WM, Rohrer RJ, Freeman RB, Schwaitzberg SD (date unknown). Multiple organ failure after liver transplantation. Vol. 23, 466-73. Accepted, .
  • Kallini JR, Gabr A, Ali R, Abouchaleh N, Riaz A, Baker T, Kulik L, Caicedo J, Salem R, Lewandowski RJ (date unknown). Pretransplant Intra-arterial Liver-Directed Therapy Does Not Increase the Risk of Hepatic Arterial Complications in Liver Transplantation: A Single-Center 10-Year Experience. Vol. 41, 231-238. Accepted, .
  • Samstein B, Smith AR, Freise CE, Zimmerman MA, Baker T, Olthoff KM, Fisher RA, Merion RM (date unknown). Complications and Their Resolution in Recipients of Deceased and Living Donor Liver Transplants: Findings From the A2ALL Cohort Study. Vol. 16, 594-602. Accepted, .
  • Chang Y, Gallon L, Shetty K, Chang Y, Jay C, Levitsky J, Ho B, Baker T, Ladner D, Friedewald J, Abecassis M, Hazen G, Skaro AI (date unknown). Simulation modeling of the impact of proposed new simultaneous liver and kidney transplantation policies. Vol. 99, 424-30. Accepted, .
  • Emond JC, Fisher RA, Everson G, Samstein B, Pomposelli JJ, Zhao B, Forney S, Olthoff KM, Baker TB, Gillespie BW, Merion RM (date unknown). Changes in liver and spleen volumes after living liver donation: a report from the Adult-to-Adult Living Donor Liver Transplantation Cohort Study (A2ALL). Vol. 21, 151-61. Accepted, .
  • Heyer EJ, Lee KS, Manspeizer HE, Mongero L, Spanier TB, Caliste X, Esrig B, Smith C (date unknown). Heparin-bonded cardiopulmonary bypass circuits reduce cognitive dysfunction. Vol. 16, 37-42. Accepted, .
  • Halpain S, Spanier T, McEwen BS (date unknown). Loss of 3H-corticosterone binding capacity in hippocampal slices maintained in vitro. Vol. 16, 167-70. Accepted, .
  • Ahmed O, Salaskar AL, Zangan S, Pillai A, Baker T (date unknown). Transsplenic portal vein recanalization and direct intrahepatic portosystemic shunt placement to optimize liver transplantation. Vol. 3, 5. Accepted, .
  • Wolf JH, Holmes MV, Fouraschen S, Keating BJ, Baker T, Emond J, Rader DJ, Shaked A, Olthoff KM (date unknown). Serum lipid expression correlates with function and regeneration following living donor liver transplantation. Vol. 22, 103-10. Accepted, .
  • Olthoff KM, Emond JC, Shearon TH, Everson G, Baker TB, Fisher RA, Freise CE, Gillespie BW, Everhart JE (date unknown). Liver regeneration after living donor transplantation: adult-to-adult living donor liver transplantation cohort study. Vol. 21, 79-88. Accepted, .
  • Nasraway SA, Klein RD, Spanier TB, Rohrer RJ, Freeman RB, Rand WM, Benotti PN (date unknown). Hemodynamic correlates of outcome in patients undergoing orthotopic liver transplantation. Evidence for early postoperative myocardial depression. Vol. 107, 218-24. Accepted, .
  • Ebong IA, Sayer G, Kim G, Jeevanandam V, Baker T, Becker Y, Fung J, Charlton M, Te H, Josephson M, Uriel N (date unknown). Simultaneous heart, liver and kidney transplantation: A viable option for heart failure patients with multiorgan failure. (pp. 997-999). Vol. 38. Accepted, .